About

The startup develops synthetic cannabidiol and cannabigerol-based drug products for the treatment of inflammatory, autoimmune, and neurodegenerative diseases. By creating two families of new chemical entities, the company targets significant gaps in effective therapies for these conditions.

What does do?

The startup develops synthetic cannabidiol and cannabigerol-based drug products for the treatment of inflammatory, autoimmune, and neurodegenerative diseases. By creating two families of new chemical entities, the company targets significant gaps in effective therapies for these conditions.

Where is located?

is based in San Diego, United States.

Location
San Diego, United States
0

Find Investable Startups and Competitors

Search thousands of startups using natural language

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

The startup develops synthetic cannabidiol and cannabigerol-based drug products for the treatment of inflammatory, autoimmune, and neurodegenerative diseases. By creating two families of new chemical entities, the company targets significant gaps in effective therapies for these conditions.

emeraldpharma.com
San Diego, United States

Funding

No funding information available.

Team

No team information available.
Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.